Severity and threshold of peanut reactivity during hospital-based open oral food challenges: An international multicenter survey

Pediatr Allergy Immunol. 2018 Nov;29(7):754-761. doi: 10.1111/pai.12959. Epub 2018 Sep 17.

Abstract

Background: Peanut allergy is classically managed by food avoidance. Immunotherapy programs are available at some academic centers for selected patients reacting to small amounts of peanut during food challenge. We aimed to determine and compare reaction thresholds and prevalence of anaphylaxis during peanut oral challenges at multiple specialist allergy centers.

Methods: A retrospective, international survey of anonymized case records from seven specialist pediatric allergy centers from the UK and Ireland, as well as the Australian HealthNuts study. Demographic information, allergy test results, reaction severity and threshold during open oral peanut challenges were collated and analyzed.

Results: Of the 1634 children aged 1-18 years old included, 525 (32%) failed their peanut challenge. Twenty-eight percent reacted to 25 mg, while 38% only reacted after consuming 1 g or more of whole peanut. Anaphylaxis (55 [11%]) was 3 times more common in teenagers than younger children and the likelihood increased at all ages as children consuming more peanut at the challenge. Children who developed anaphylaxis to 25-200 mg of whole peanut were significantly older. Previous history of reaction did not predict reaction threshold or severity.

Conclusions: More than a third of the children in this large international cohort tolerated the equivalent of one peanut in an oral challenge. Anaphylaxis, particularly to small amounts of peanut, was more common in older children. Tailored immunotherapy programs might be considered not only for children with low, but also higher reaction thresholds. Whether these programs could prevent heightened sensitivity and anaphylaxis to peanut with age also deserves further study.

Keywords: anaphylaxis; children; food allergy; oral food challenge; peanut; threshold.

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Adolescent
  • Allergens / immunology
  • Anaphylaxis / diagnosis*
  • Anaphylaxis / epidemiology
  • Anaphylaxis / etiology
  • Arachis / immunology
  • Australia
  • Child
  • Child, Preschool
  • Desensitization, Immunologic / adverse effects*
  • Desensitization, Immunologic / methods
  • Female
  • Hospitals
  • Humans
  • Immunoglobulin E / blood
  • Infant
  • Ireland
  • Male
  • Peanut Hypersensitivity / immunology*
  • Peanut Hypersensitivity / therapy
  • Retrospective Studies
  • Sensitivity and Specificity
  • Severity of Illness Index
  • Skin Tests / methods
  • Surveys and Questionnaires
  • United Kingdom

Substances

  • Allergens
  • Immunoglobulin E